Delivery Order SPE2DB20D1051-SPE2DB25FD8WB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,081.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 10, 2025. This firm fixed price delivery order, with an ultimate completion date of September 11, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 12.5 mg/0.5 mL pen injections on August 29, 2025, with completion scheduled for September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $6,560.81 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pens on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,245.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,537.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens in 0.5 mL unit doses. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $60,990.95 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (tirzepatide), a diabetes treatment medication. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen (tirzepatide injection), a diabetes and weight management medication. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is to be completed by August 26, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,845.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfillment through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $12,759.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD8WBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,645.08 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a single delivery order for the diabetes medication to support federal healthcare needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The parent contract reflects DLA's reliance on AmerisourceBergen as a critical pharmaceutical distributor for federal medical procurement, with the company demonstrating substantial capability to fulfill both routine and specialized medication needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/22/25 |